Clinical trials · Salt Lake City, UT
Relapsed/Refractory Multiple Myeloma clinical trials in Salt Lake City
We’re tracking 6 recruiting relapsed/refractory multiple myeloma studies with a site in or near Salt Lake City — including Phase 1 and Phase 1/Phase 2 studies, each written for real people, not researchers.
Recruiting studies near Salt Lake City
- NCT07280013RecruitingPhase 1
Cemsidomide with elranatamab for multiple myeloma
This trial tests a new drug combination (cemsidomide and elranatamab) for people with multiple myeloma that has come back after previous treatments. The goal is to see if the combination is safe and works better than current options.
Salt Lake City, UtahAges 18 years+ - NCT05722418RecruitingPhase 1
CRISPR-edited CAR-T for harder-to-treat myeloma
This Phase 1 study tests a lab-made immune cell therapy (CAR-T) made from a donor, with a CRISPR edit, for multiple myeloma that has come back or not responded to treatment. It aims to find the safest way to give the treatment and see how well it can control the cancer.
Salt Lake City, UtahAges 18 years+ - NCT05850234RecruitingPhase 1/Phase 2
Study drug for hard-to-treat multiple myeloma after prior treatments
This Phase 1/2 study tests AZD0120 in people with multiple myeloma that has come back or is not responding to treatment. It may help by targeting the myeloma cells after you’ve already tried several standard therapies.
Salt Lake City, UtahAges 18 years+ - NCT04988555RecruitingPhase 1/Phase 2
Study of an investigational drug for high-risk acute leukemia
This Phase 1/2 study tests enzomenib (DSP-5336) in people with relapsed or hard-to-treat acute leukemia (and, in some places, certain other blood cancers). The goal is to see how the drug works and how safe it is, especially for leukemia cases with specific genetic changes (KMT2A/MLL or NPM1).
Salt Lake City, UtahAges 12 years+ - NCT04973605RecruitingPhase 1/Phase 2
Sonrotoclax with steroid and other drugs for multiple myeloma
This early-phase study tests sonrotoclax (a cancer medicine) in people with multiple myeloma that has come back or not responded to prior treatment. It also studies different combinations with dexamethasone plus other standard medicines, aiming to shrink tumors and improve control of the disease.
Salt Lake City, UtahAges 18 years+ - NCT05332054Enrolling by invitation
Long-term follow-up after prior Caribou treatment
This study checks your health over time after you previously took a Caribou medicine (or got it through a special access program). It helps researchers learn what happens in the longer run after the treatment.
Salt Lake City, UtahAges 18 years+
Hear when a new Relapsed/Refractory Multiple Myeloma trial opens near Salt Lake City, UT
We’ll email you when one opens near Salt Lake City, UT — at most once a week, no account needed, unsubscribe anytime.
Relapsed/Refractory Multiple Myeloma trials in other cities
Where these studies are running near Salt Lake City
Institutions with a site for the recruiting relapsed/refractory multiple myeloma studies listed above.
- Huntsman Cancer Institute/University of Utah · 5 studies
- Intermountain Health
- Research Site
What taking part in a relapsed/refractory multiple myeloma study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting relapsed/refractory multiple myeloma studies in Utah.
Common questions
- Are there relapsed/refractory multiple myeloma clinical trials near Salt Lake City?
- Yes. We're currently tracking 6 recruiting relapsed/refractory multiple myeloma studies with a site near Salt Lake City, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a relapsed/refractory multiple myeloma study near Salt Lake City?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Salt Lake City to take part?
- Not necessarily. These studies have a site near Salt Lake City, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a relapsed/refractory multiple myeloma trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New relapsed/refractory multiple myeloma studies open near Salt Lake City regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.